Propofol for Supreme LMA Insertion With and Without Remifentanil
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The aims of this study were to determine the clinically required concentration of propofol
for LMA Supreme insertion, and to examine to what extent remifentanil reduces the dose of
propofol and improves conditions for it's insertion.